Editorial: Interferon and its antiviral effect in response to HBV infection

Hongxiao Song; Yongye Huang; Chunfeng Li; Quan Liu; Guangyun Tan

doi:10.3389/fimmu.2023.1135649

Editorial: Interferon and its antiviral effect in response to HBV infection

Front Immunol. 2023 Feb 2:14:1135649. doi: 10.3389/fimmu.2023.1135649. eCollection 2023.

Authors

Hongxiao Song¹, Yongye Huang², Chunfeng Li³, Quan Liu⁴, Guangyun Tan¹

Affiliations

¹ Department of Hepatology, Infectious Diseases and Pathogen Biology Center, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
² College of Life and Health Sciences, Northeastern University, Shenyang, China.
³ Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, United States.
⁴ Department of Infectious Diseases, Infectious Diseases and Pathogen Biology Center, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, China.

No abstract available

Keywords: CccDNA; HBV - hepatitis B virus; HCC (hepatic cellular carcinoma); ISGs; ISGs (IFN-stimulated genes); interferon.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents*
Hepatitis B virus* / physiology
Hepatocytes
Interferon-alpha

Substances

Antiviral Agents
Interferon-alpha

Grants and funding

This work was supported by the International Cooperation Project of Jilin Provincial Science and Technology Department (Grant No. 20220402085GH to GT) and Bethune Project of Jilin University (Grant No. 2022B12 to GT).